Page last updated: 2024-08-21

chenodeoxycholic acid and Disease Models, Animal

chenodeoxycholic acid has been researched along with Disease Models, Animal in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-19909 (11.11)18.7374
1990's3 (3.70)18.2507
2000's8 (9.88)29.6817
2010's48 (59.26)24.3611
2020's13 (16.05)2.80

Authors

AuthorsStudies
Carino, A; Cipriani, S; D'Amore, C; De Marino, S; Festa, C; Finamore, C; Fiorucci, S; Monti, MC; Renga, B; Sepe, V; Zampella, A1
Balasubramaniyan, N; Devereaux, MW; Orlicky, DJ; Sokol, RJ; Suchy, FJ1
Dai, Z; Fernandez, JA; Griffin, JH; Huuskonen, MT; Lazic, D; Montagne, A; Nikolakopoulou, AM; Sagare, AP; Wang, Y; Zhao, Z; Zlokovic, BV1
Adorini, L; Brescia, P; Galbiati, M; Invernizzi, P; Mileti, E; Mouries, J; Penna, G; Rescigno, M; Silvestri, A; Sorribas, M; Spadoni, I; Wiest, R1
Feng, W; Hao, Z; Liu, Y; Ren, L; Song, Q; Zhang, L1
Chen, Q; Gai, Z; Gui, T; Guo, X; Liu, J; Ma, H1
Cui, S; Ge, C; Gonzalez, FJ; Guo, Y; Hao, H; He, Q; Huang, N; Pan, X; Wang, G; Wang, H; Zhang, P; Zhou, J1
Bian, Z; Ge, K; Han, X; Huang, F; Jia, W; Li, M; Qu, C; Rajani, C; Wang, S; Wei, M; Xie, G; Yang, W; Zhang, Y; Zhao, A; Zhao, L; Zheng, X1
Bi, Y; Cheng, W; Ding, J; Li, M; Ni, Z; Sun, S; Yu, C; Yu, J; Zhou, L1
Andersen, H; Divanovic, S; Haslam, DB; Horrigan, O; Jose, S; Madan, R; Moreno-Fernandez, ME; Mukherjee, A; Setchell, KDR; Sharma, D; Zhang, W1
Attema, J; Caspers, MPM; de Ruiter, C; Kleemann, R; Menke, AL; Radhakrishnan, S; Salic, K; van den Hoek, AM; van Nieuwkoop, A; Verschuren, L; Worms, N1
Chen, J; Chen, LF; Chiang, CM; Hu, X; Jung, H; Kemper, B; Kemper, JK; Sun, H; Wu, SY1
Iguchi, Y; Inoue, R; Ito, K; Okumura, A; Sakamoto, K; Takeuchi, JS; Umezawa, K; Une, M; Wakita, T; Watashi, K; Yamashita, Y; Yamauchi, T; Yoneda, M1
Chen, J; Han, Y; Li, L; Teufel, A; Wang, B; Weng, H; Wu, L; Yao, Y; Yue, S; Zheng, Z; Zhu, S1
Duan, Y; Gao, Y; Guo, D; He, L; Jiang, W; Jin, C; Lin, H; Qiu, W; Wang, L; Yang, R; Yao, J; Zhang, L; Zhou, Y1
Chen, J; Gu, X; Luo, H; Su, C; Tang, J; Xiao, L; Xiong, F; Zha, L; Zhao, Y; Zheng, Z1
Dan, J; Habuchi, H; Habuchi, O; Ikeuchi, M; Izumi, M; Takeuchi, K; Ushida, T1
Bowlus, C; Floreani, A; Gershwin, ME; Tanaka, A1
Afonso, MB; Borralho, PM; Carvalho, CC; Castro, RE; Cortez-Pinto, H; Duarte, A; Machado, MV; Rodrigues, CM; Rodrigues, PM; Simão, AL; Trindade, A1
Adorini, L; Aldini, R; Camborata, C; Cont, M; D'Errico, A; Degiovanni, A; Franco, P; Maroni, L; Roda, A; Spinozzi, S; Vasuri, F1
Claudel, T; Fuchs, CD; Scharnagl, H; Stojakovic, T; Trauner, M1
Andreone, P; Gitto, S; Guarneri, V; Sartini, A1
Briand, F; Brousseau, E; Burcelin, R; Quinsat, M; Sulpice, T1
Feigh, M; Gillum, MP; Hansen, HH; Jelsing, J; Kristiansen, MN; Rigbolt, KT; Tølbøl, KS; Veidal, SS; Vrang, N1
Blomenkamp, K; Greenspon, J; Guzman, MA; Heafner, N; Kakarla, V; Korremla, N; Kumar Jain, A; Manithody, C; Phillips, W; Pochampally, S; Price, A; Ratchford, T; Saxena, S; Villalona, G; Westrich, M1
Cremonesi, A; Gai, Z; Gui, T; Hartling, I; Häusler, S; Hiller, C; Kullak-Ublick, GA; Thasler, WE; Visentin, M; Zhao, L1
Asakawa, M; Goto, T; Itoh, M; Kai, T; Kanai, S; Ogawa, Y; Sakai, T; Shirakawa, I; Suganami, T; Yoneyama, T1
Adorini, L; Cellai, I; Comeglio, P; Corno, C; Filippi, S; Maggi, M; Morelli, A; Pini, A; Sarchielli, E; Vannelli, GB; Vignozzi, L1
Duan, Y; Li, B; Qin, H; Wei, M; Wu, X; Wu, Y; Xi, L; Zhang, F; Zhou, Y1
Chen, YH; Li, J; Luo, B; Song, J; Song, YP; Xie, DD; Xu, DX; Xu, S; Yu, DX; Zhang, ZH; Zhu, JB1
Alles, LK; Damink, SWO; de Haan, L; de Waart, DR; Ergin, B; Heger, M; Jansen, PL; Lionarons, DA; Maas, A; Olthof, PB; Reiniers, MJ; Schaap, FG; Uz, Z; van Golen, RF; van Gulik, TM; Verheij, J1
Chen, YH; Fei, J; Fu, L; Hu, B; Li, JB; Xu, DX; Zhao, H1
Adorini, L; Cellai, I; Comeglio, P; Corno, C; Filippi, S; Maggi, M; Morelli, A; Sarchielli, E; Vannelli, GB; Vignozzi, L1
Oda, S; Takeuchi, T; Tsuneyama, K; Yang, F; Yokoi, T1
Adorini, L; Feigh, M; Fensholdt, LKD; Hansen, HH; Jelsing, J; Nielsen, JC; Papazyan, R; Rigbolt, KTG; Roth, JD; Veidal, SS; Vrang, N; Young, M1
Adorini, L; Bellafante, E; Fan, HM; Jansen, E; Jones, P; Marchesi, JR; Marschall, HU; McDonald, JAK; McIlvride, S; Nikolova, V; Shapiro, D; Wahlström, A; Williamson, C1
Elst, IV; Farre, R; Klein, S; Komuta, M; Laleman, W; Nevens, F; Roskams, T; Trebicka, J; Vanuytsel, T; Verbeke, L; Windmolders, P1
DeMorrow, S; Frampton, G; Galindo, C; McMillin, M; Pae, HY; Quinn, M1
Eloranta, JJ; Gai, Z; Kullak-Ublick, GA; Mwinyi, J; Schaffner, CA; Thasler, WE1
Bonde, Y; Rudling, M1
Narala, VR; Narasimha, VR; Panati, K; Shaik, FB1
Chi, X; Lan, X; Li, C; Li, J; Weng, X1
Lian, F; Liang, L; Wang, Y; Wu, X; Xiao, Y; Xu, H; Yang, X1
Dong, J; He, CY; Miao, LY; Qin, CH; Yan, ZW; Zhao, CY1
Chen, D; Chen, W; Liu, HL; Wang, X; Wu, ZH; Zeng, TS; Zhang, HM; Zhang, ZZ1
Berends, FJ; Betzel, B; Hollman, DAA; Ijssennagger, N; Janssen, AWF; Janssen, IM; Kersten, S; Milona, A; Mokry, M; Ramos Pittol, JM; van Mil, SWC1
Farre, R; Govaere, O; Klein, S; Laleman, W; Mannaerts, I; Mazzone, M; Nevens, F; Schierwagen, R; Trebicka, J; van Grunsven, LA; Vander Elst, I; Verbeke, L; Wenes, M; Windmolders, P1
Ali, MS; Bishop-Bailey, D; Bye, AP; Dombrowicz, D; Dorchies, E; Flora, GD; Gibbins, JM; Kriek, N; Molendi-Coste, O; Moraes, LA; Sage, T; Sasikumar, P; Staels, B; Unsworth, AJ; Vaiyapuri, S1
Barn, V; Farrell, GC; Geoffrey Haigh, W; Haczeyni, F; Ioannou, GN; Leclercq, IA; Mridha, AR; Poekes, L; Teoh, NC; Wang, H; Yeh, MM1
Cai, W; Chen, Y; Gong, Z; Tian, C; Wang, P; Wu, J; Xu, C; Zhao, S; Zhou, J1
Ceulemans, LJ; De Hertogh, G; Decuypere, JP; Farré, R; Jochmans, I; Laleman, W; Lenaerts, K; Monbaliu, D; Nevens, F; Pirenne, J; Tack, J; Verbeke, L1
Adorini, L; Cellai, I; Comeglio, P; Corcetto, F; Corno, C; Filippi, S; Maggi, M; Maneschi, E; Morelli, A; Pini, A; Sarchielli, E; Vannelli, GB; Vignozzi, L1
Distrutti, E; Fiorucci, S; Mencarelli, A; Renga, B1
Burgermeister, E; Ebeling, M; Ebert, MP; Einwächter, H; Fan, L; Geisler, F; Hiber, M; Rauser, S; Röcken, C; Schmid, RM; Walch, A; Wright, MB; Xing, X1
Fujimoto, Y; Iida, T; Yasukawa, K1
Cipriani, S; Fiorucci, S; Mencarelli, A; Palladino, G1
Kratzer, A; Levi, M; Lewis, LB; Miyazaki, M; Miyazaki-Anzai, S; Ting, TC1
Adorini, L; Danese, S; Gadaleta, RM; Klomp, LW; Laverny, G; Moschetta, A; Murzilli, S; Oldenburg, B; Penna, G; Renooij, W; Schipper, ME; Siersema, PD; van Erpecum, KJ; van Mil, SW; Willemsen, EC1
Chen, J; Chen, M; Lian, F; Liang, L; Wang, Y; Xu, H; Yang, X; Ye, Y; Zhan, Z1
Baldelli, F; Bifulco, G; Cipriani, S; Fiorucci, S; Mencarelli, A; Zampella, A1
Adorini, L; Carini, M; Cellai, I; Comeglio, P; Filippi, S; Gacci, M; Maggi, M; Maneschi, E; Morelli, A; Piccinni, MP; Saad, F; Sarchielli, E; Serni, S; Vannelli, GB; Vignozzi, L1
Burrin, DG; Holst, JJ; Jain, AK; Moore, DD; Stoll, B1
Adorini, L; Carini, M; Cellai, I; Comeglio, P; Filippi, S; Gacci, M; Maggi, M; Maneschi, E; Morelli, A; Sarchielli, E; Vannelli, GB; Vignozzi, L; Yehiely-Cohen, R1
Hu, Z; Liu, B; Ren, L; Song, G; Wang, C1
Bouscarel, B; Ceryak, S; Doy, M; Fukushima, S; Honda, A; Ikegami, T; Matsuzaki, Y; Shoda, J; Tanaka, N; Yoshida, S1
Seyama, Y1
Alvarez, AR; Amigo, L; Ferrada, C; Galdames, L; Klein, A; Miquel, JF; Morales, MG; Quinones, V; Rigotti, A; Rio, MC; Tichauer, JE; Zanlungo, S1
Schwaier, A; van der Linden, J; Weis, HJ1
Mitschke, H; Sauer, HD; Thoma, G; Winkler, R1
Bertagnolli, MM; Bilinski, RT; Chadburn, A; Churchill, M; Dannenberg, AJ; Mahmoud, NN; Martucci, C; Mestre, JR1
Deleuran, B; Jakobsen, NO; Jensen, SL; Kristensen, JU; Larsen, CG; Lausten, SB; Osman, MO1
Lagoo, A; McMurray, RW; Suwannaroj, S1
Aki, H; Goto, M; Okamoto, Y; Yamamoto, M1
Eastwood, GL1
Bonorris, GG; Chung, A; Marks, JW; Pearlman, BJ; Phillips, MJ; Schoenfield, LJ; Vimadalal, S1
Baggenstoss, AH; Hofmann, AF; Lancaster, MC; Wease, DF; Webster, KH1
Ceryak, S; Fromm, H; Malavolti, M; Shehan, KL1
Jeynes, BJ1
Cohen, BI; Kuroki, S; McSherry, CK; Mosbach, EH1
Poncelet, PR; Thompson, AG1
Bell, S; Connor, WE; DenBesten, L; Safaie-Shirazi, S1

Reviews

3 review(s) available for chenodeoxycholic acid and Disease Models, Animal

ArticleYear
Geoepidemiology and changing mortality in primary biliary cholangitis.
    Journal of gastroenterology, 2017, Volume: 52, Issue:6

    Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Models, Animal; Drug Design; Fluorescent Antibody Technique, Indirect; Humans; Liver Cirrhosis, Biliary; Precision Medicine; Ursodeoxycholic Acid

2017
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.
    Expert review of gastroenterology & hepatology, 2018, Volume: 12, Issue:2

    Topics: Animals; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Disease Models, Animal; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Outcome

2018
Cholestanol metabolism, molecular pathology, and nutritional implications.
    Journal of medicinal food, 2003,Fall, Volume: 6, Issue:3

    Topics: Animals; Calcium Channels; Cell Membrane; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; Cholesterol; Disease Models, Animal; Mice; Mutation; Rats; Steroid Hydroxylases; Xanthomatosis, Cerebrotendinous

2003

Other Studies

78 other study(ies) available for chenodeoxycholic acid and Disease Models, Animal

ArticleYear
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands.
    Journal of medicinal chemistry, 2014, Oct-23, Volume: 57, Issue:20

    Topics: Animals; Bile Acids and Salts; Chemistry Techniques, Synthetic; Cholanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; HEK293 Cells; Hep G2 Cells; Humans; Ligands; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Molecular Targeted Therapy; Pruritus; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Small Molecule Libraries; Structure-Activity Relationship

2014
miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis.
    The Journal of biological chemistry, 2021, Volume: 297, Issue:6

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Chenodeoxycholic Acid; Cholestasis; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Knockout; MicroRNAs; Nuclear Receptor Co-Repressor 1

2021
Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C.
    The Journal of experimental medicine, 2022, 01-03, Volume: 219, Issue:1

    Topics: Animals; Blood-Brain Barrier; Chenodeoxycholic Acid; Corpus Callosum; Disease Models, Animal; Enzyme Activation; Fibrinolytic Agents; Humans; Ischemia; Male; Mice, Inbred C57BL; Neuroprotective Agents; Oligodendroglia; Protein C; Receptor, PAR-1; Receptors, Thrombin; Stroke; White Matter

2022
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Journal of hepatology, 2019, Volume: 71, Issue:6

    Topics: Animals; Bacterial Translocation; Capillary Permeability; Chenodeoxycholic Acid; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Insulin Resistance; Intestinal Mucosa; Liver; Mice; Non-alcoholic Fatty Liver Disease; Protective Agents

2019
Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury.
    Biochemical and biophysical research communications, 2019, 11-26, Volume: 520, Issue:1

    Topics: Angiogenic Proteins; Animals; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cytokines; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Lacticaseibacillus rhamnosus; Liver; Male; Mice; Mice, Inbred C57BL; Pregnanolone; Probiotics; RNA-Binding Proteins; Signal Transduction; Ursodeoxycholic Acid

2019
Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Dec-08, Volume: 25

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Cell Line; Chenodeoxycholic Acid; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Hippocampus; Humans; Mice; Neurons; Receptors, Cytoplasmic and Nuclear; Signal Transduction

2019
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.
    Nature communications, 2020, 01-13, Volume: 11, Issue:1

    Topics: Animals; Cells, Cultured; Chenodeoxycholic Acid; Disease Models, Animal; Drug Therapy, Combination; Hepatic Stellate Cells; Humans; Lipid Droplets; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Perilipin-1; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Transcriptional Activation; Treatment Outcome

2020
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility.
    EBioMedicine, 2020, Volume: 55

    Topics: Adipose Tissue, Brown; Animals; Body Mass Index; Chenodeoxycholic Acid; Cholestenones; Clostridiales; Cohort Studies; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Gastrointestinal Microbiome; Gene Expression Regulation; Glucagon-Like Peptide 1; Humans; Ileum; Lithocholic Acid; Male; Metagenomics; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Uncoupling Protein 1; Ursodeoxycholic Acid

2020
Correlation of fecal metabolomics and gut microbiota in mice with endometriosis.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2020, Volume: 84, Issue:6

    Topics: alpha-Linolenic Acid; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Disease Models, Animal; Dysbiosis; Endometriosis; Feces; Female; Gastrointestinal Microbiome; Humans; Metabolomics; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S

2020
Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice.
    Mucosal immunology, 2021, Volume: 14, Issue:2

    Topics: Animals; Anticholesteremic Agents; Chenodeoxycholic Acid; Clostridioides difficile; Clostridium Infections; Diet, High-Fat; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; RNA-Binding Proteins

2021
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
    Cells, 2020, 09-01, Volume: 9, Issue:9

    Topics: Animals; Atherosclerosis; Chenodeoxycholic Acid; Diet, High-Fat; Disease Models, Animal; Fast Foods; Hyperinsulinism; Hyperlipidemias; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Receptors, LDL; Transcriptome; Treatment Outcome

2020
BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
    JCI insight, 2020, 12-08, Volume: 6, Issue:1

    Topics: Animals; Azepines; Bile Acids and Salts; Cell Cycle Proteins; Chenodeoxycholic Acid; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Drug Interactions; Gene Knockdown Techniques; Humans; Liver; Liver Cirrhosis, Biliary; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Nuclear Proteins; Nuclear Receptor Co-Repressor 2; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Triazoles

2020
Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:1

    Topics: Animals; Antiviral Agents; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Disease Models, Animal; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Mice; Organic Anion Transporters, Sodium-Dependent; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Symporters; Transplantation Chimera; Virus Internalization

2021
Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice.
    Nutrients, 2021, Mar-15, Volume: 13, Issue:3

    Topics: Animals; Anxiety; Behavior, Animal; Brain; Chenodeoxycholic Acid; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Microglia; Sugars

2021
Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway.
    International journal of molecular sciences, 2021, Apr-07, Volume: 22, Issue:8

    Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Cartilage; Cell Line; Cell Survival; Chenodeoxycholic Acid; Cytokines; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Male; Mice; NF-kappa B; Nitric Oxide; Osteoarthritis; RAW 264.7 Cells; Signal Transduction

2021
Soyasaponin A
    Molecular nutrition & food research, 2021, Volume: 65, Issue:14

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Choline Deficiency; Colon; Diet; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Liver; Male; Methionine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Saponins

2021
Bone marrow derived mast cells injected into the osteoarthritic knee joints of mice induced by sodium monoiodoacetate enhanced spontaneous pain through activation of PAR2 and action of extracellular ATP.
    PloS one, 2021, Volume: 16, Issue:6

    Topics: Adenosine Triphosphate; Animals; Arthritis, Experimental; Bone Marrow Cells; Chemokine CXCL2; Chenodeoxycholic Acid; Chronic Pain; Disease Models, Animal; Knee Joint; Male; Mast Cells; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligopeptides; Receptor, PAR-2; Receptors, Purinergic; Synovial Fluid

2021
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice.
    Cell death & disease, 2017, 04-13, Volume: 8, Issue:4

    Topics: Animals; Apoptosis; Chenodeoxycholic Acid; Disease Models, Animal; Fast Foods; Inflammation; Liver Cirrhosis; Male; Mice; Mice, Knockout; MicroRNAs; Non-alcoholic Fatty Liver Disease; PPAR alpha; Receptors, Cytoplasmic and Nuclear

2017
Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis.
    Clinical and translational science, 2017, Volume: 10, Issue:4

    Topics: Animals; Bile Acids and Salts; Biliary Fistula; Chenodeoxycholic Acid; Disease Models, Animal; Feces; Intestinal Mucosa; Intestines; Liver; Liver Cirrhosis; Male; Metabolome; Metabolomics; Rats, Wistar; Tissue Distribution

2017
FXR controls CHOP expression in steatohepatitis.
    FEBS letters, 2017, Volume: 591, Issue:20

    Topics: Animals; Binding Sites; Chenodeoxycholic Acid; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Promoter Regions, Genetic; Protein Binding; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptors; RNA, Messenger; Signal Transduction; Transcription Factor CHOP; Tretinoin

2017
Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model.
    European journal of pharmacology, 2018, Jan-05, Volume: 818

    Topics: Animals; Body Weight; CD36 Antigens; Chenodeoxycholic Acid; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Diet; Disease Models, Animal; Dyslipidemias; Gene Expression Regulation; Insulin Resistance; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Receptors, LDL

2018
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    World journal of gastroenterology, 2018, Jan-14, Volume: 24, Issue:2

    Topics: Animals; Biopsy; Chalcones; Chenodeoxycholic Acid; Collagen Type I; Collagen Type I, alpha 1 Chain; Diet, High-Fat; Disease Models, Animal; Galectin 3; Lipid Metabolism; Liraglutide; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Propionates; Time Factors; Weight Gain

2018
No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
    JPEN. Journal of parenteral and enteral nutrition, 2018, Volume: 42, Issue:8

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Fibroblast Growth Factors; Gastrointestinal Tract; Intestine, Small; Liver; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Total; Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Cytoplasmic and Nuclear; Short Bowel Syndrome; Swine

2018
Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.
    Molecular pharmacology, 2018, Volume: 94, Issue:2

    Topics: Animals; Arachidonic Acid; Cell Movement; Cells, Cultured; Chenodeoxycholic Acid; Cytochrome P-450 Enzyme System; Diet, High-Fat; Disease Models, Animal; Female; Gene Expression Regulation; Hepatocytes; Humans; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; THP-1 Cells

2018
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis.
    Scientific reports, 2018, 05-25, Volume: 8, Issue:1

    Topics: Animals; Body Weight; Cell Death; Chenodeoxycholic Acid; Cytoprotection; Disease Models, Animal; Disease Progression; Gene Knockout Techniques; Hepatocytes; Insulin Resistance; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Receptor, Melanocortin, Type 4; Tumor Suppressor Protein p53

2018
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.
    Journal of endocrinological investigation, 2019, Volume: 42, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Bleomycin; Chenodeoxycholic Acid; Disease Models, Animal; Epithelial-Mesenchymal Transition; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley

2019
The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Oct-15, Volume: 123

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Cell Line; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestasis, Intrahepatic; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Ethinyl Estradiol; Humans; Ileum; Liver; Male; Molecular Docking Simulation; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Steroid 12-alpha-Hydroxylase; Up-Regulation

2018
Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury.
    European journal of pharmacology, 2018, Nov-05, Volume: 838

    Topics: Acute Kidney Injury; Administration, Oral; Animals; Chenodeoxycholic Acid; Disease Models, Animal; Humans; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nephritis; Oxidative Stress; Receptors, Cytoplasmic and Nuclear

2018
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis.
    Scientific reports, 2018, 11-08, Volume: 8, Issue:1

    Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; cdc25 Phosphatases; Chenodeoxycholic Acid; Cholestasis; Cyclin D1; Disease Models, Animal; Fibroblast Growth Factors; Gene Expression Regulation; Liver Regeneration; Male; Organ Size; Rats

2018
Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice.
    International immunopharmacology, 2019, Volume: 66

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Chenodeoxycholic Acid; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-kappa B; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Tumor Necrosis Factor-alpha

2019
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.
    Journal of endocrinological investigation, 2019, Volume: 42, Issue:8

    Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Chenodeoxycholic Acid; Disease Models, Animal; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear

2019
Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.
    Toxicological sciences : an official journal of the Society of Toxicology, 2019, 07-01, Volume: 170, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Disease Models, Animal; Drug Synergism; Female; Ketoconazole; Liver; Liver Function Tests; Rats, Sprague-Dawley

2019
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH.
    Scientific reports, 2019, 06-21, Volume: 9, Issue:1

    Topics: Animals; Biopsy; Chalcones; Chenodeoxycholic Acid; Disease Models, Animal; Liver Cirrhosis; Mice; PPAR alpha; Proof of Concept Study; Propionates; Transcription, Genetic

2019
Obeticholic acid ameliorates dyslipidemia but not glucose tolerance in mouse model of gestational diabetes.
    American journal of physiology. Endocrinology and metabolism, 2019, 08-01, Volume: 317, Issue:2

    Topics: Animals; Blood Glucose; Chenodeoxycholic Acid; Diabetes, Gestational; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Female; Glucose Intolerance; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Pregnancy; Pregnancy Complications

2019
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:6

    Topics: Animals; Chenodeoxycholic Acid; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Hypertension, Portal; Liver Cirrhosis; Male; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Signal Transduction

2014
Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:6

    Topics: Aminoquinolines; Animals; Bile Ducts; Blood-Brain Barrier; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Disease Models, Animal; Endothelial Cells; Ligation; Male; Microvessels; Occludin; Permeability; Phosphorylation; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tight Junctions; Tissue Culture Techniques; Zonula Occludens-1 Protein; Zonula Occludens-2 Protein

2014
The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:4

    Topics: Animals; Binding Sites; Cell Hypoxia; Cell Line; Chenodeoxycholic Acid; Disease Models, Animal; Hepatocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Failure, Chronic; Liver; Membrane Transport Proteins; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Response Elements; RNA Interference; Transfection; Up-Regulation

2015
Stimulation of apical sodium-dependent bile acid transporter expands the bile acid pool and generates bile acids with positive feedback properties.
    Digestive diseases (Basel, Switzerland), 2015, Volume: 33, Issue:3

    Topics: Ampicillin; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Deoxycholic Acid; Disease Models, Animal; Feedback, Physiological; Humans; Mice; Mice, Knockout; Organic Anion Transporters, Sodium-Dependent; Phenotype; Receptors, Cytoplasmic and Nuclear; Symporters

2015
Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the T(H)2 cytokines.
    Biochemical and biophysical research communications, 2015, Aug-07, Volume: 463, Issue:4

    Topics: Animals; Asthma; Base Sequence; Bronchitis; Chenodeoxycholic Acid; Cytokines; Disease Models, Animal; DNA Primers; Female; Mice; Mice, Inbred BALB C; Ovalbumin; Th2 Cells

2015
Farnesoid X receptor agonist CDCA reduces blood pressure and regulates vascular tone in spontaneously hypertensive rats.
    Journal of the American Society of Hypertension : JASH, 2015, Volume: 9, Issue:7

    Topics: Animals; Antihypertensive Agents; Chenodeoxycholic Acid; Disease Models, Animal; Endothelin-1; Hypertension; Mesenteric Arteries; NF-kappa B; Nitric Oxide Synthase; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Vascular Cell Adhesion Molecule-1; Vasoconstriction; Vasodilation

2015
Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Caspase 3; Chenodeoxycholic Acid; Concanavalin A; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Female; Gastrointestinal Agents; Gene Expression Regulation; Hepatitis, Autoimmune; Hepatocytes; Interferon-gamma; Interleukin-2; Interleukin-4; Liver; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Tumor Necrosis Factor-alpha

2015
Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis.
    Mediators of inflammation, 2015, Volume: 2015

    Topics: Animals; Anterior Cruciate Ligament; Cartilage, Articular; Chenodeoxycholic Acid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Femur; Injections, Intra-Articular; Interleukin-1beta; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Osteoarthritis; Prostaglandins E; Rabbits; Synovial Membrane; X-Ray Microtomography

2015
Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Animals; Body Weight; Chenodeoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Gluconeogenesis; Glucose-6-Phosphatase; Liver; Male; Phosphoenolpyruvate Carboxykinase (ATP); Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors

2016
Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid.
    Journal of hepatology, 2016, Volume: 64, Issue:5

    Topics: Animals; Chenodeoxycholic Acid; Disease Models, Animal; DNA; Gene Expression Profiling; Gene Expression Regulation; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Microarray Analysis; Non-alcoholic Fatty Liver Disease; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Transcriptional Activation

2016
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
    Scientific reports, 2016, 09-16, Volume: 6

    Topics: Animals; Apoptosis; Biomarkers; Cell Cycle; Cell Line; Cell Proliferation; Chenodeoxycholic Acid; Cytokines; Disease Models, Animal; Endothelial Cells; Hemodynamics; Hepatic Stellate Cells; Hepatocytes; Humans; Inflammation; Inflammation Mediators; Kupffer Cells; Lipopolysaccharides; Liver; Liver Cirrhosis; Male; Mice; NF-kappa B; NF-KappaB Inhibitor alpha; Portal Pressure; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Thioacetamide; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Resistance

2016
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:12

    Topics: Animals; Blood Platelets; Calcium Signaling; Chenodeoxycholic Acid; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinogen; Genotype; Hemostasis; Humans; Isoxazoles; Ligands; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cytoplasmic and Nuclear; Thrombosis; Time Factors

2016
Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.
    Obesity (Silver Spring, Md.), 2017, Volume: 25, Issue:1

    Topics: Adiposity; Animals; Chenodeoxycholic Acid; Diet, Atherogenic; Disease Models, Animal; Fatty Liver; Female; Inflammation; Liver; Mice; Mice, Inbred NOD; Mice, Obese; Obesity; Weight Gain

2017
Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: Adenosine Triphosphate; Animals; Bile Ducts; Caspase 3; Caspase Inhibitors; Cell Line; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; ErbB Receptors; Inflammasomes; Interleukin-1beta; Kupffer Cells; Ligation; Liver; Liver Cirrhosis; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium; Reactive Oxygen Species; Receptors, G-Protein-Coupled; RNA Interference; Signal Transduction; Transfection

2016
Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Animals; Apoptosis; Autophagy; Biomarkers; Chenodeoxycholic Acid; Disease Models, Animal; Endotoxins; Ileum; Inflammation Mediators; Intestinal Mucosa; Intestines; Male; Permeability; Rats; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; Signal Transduction

2017
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 168

    Topics: Airway Remodeling; Animals; Bleomycin; Chenodeoxycholic Acid; Collagen; Disease Models, Animal; Fibrosis; Gene Expression Profiling; Immunohistochemistry; Inflammation; Lung; Male; Pulmonary Alveoli; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Ventricular Remodeling

2017
Antiatherosclerotic effect of farnesoid X receptor.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:2

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cardiovascular Agents; CD11b Antigen; CD36 Antigens; Chenodeoxycholic Acid; Disease Models, Animal; DNA-Binding Proteins; Female; Humans; Hyperlipidemias; Interleukin-1beta; Interleukin-6; Ligands; Lipids; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones; Toll-Like Receptor 4; Transcription Factors; Tumor Necrosis Factor-alpha

2009
Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3

    Topics: Animals; Cell Line; Cell Line, Tumor; Chenodeoxycholic Acid; Disease Models, Animal; DNA-Binding Proteins; Female; Hepatocytes; Hepatomegaly; Homeodomain Proteins; Humans; Hypertrophy; Introns; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2009
Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
    The Journal of pharmacy and pharmacology, 2009, Volume: 61, Issue:8

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Bile Acids and Salts; Carcinogens; Chenodeoxycholic Acid; Disease Models, Animal; Edema; Female; Indomethacin; Inflammation; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate

2009
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.
    Journal of lipid research, 2010, Volume: 51, Issue:4

    Topics: Animals; Chenodeoxycholic Acid; Disease Models, Animal; Drug Therapy, Combination; Fatty Liver; Gene Expression Regulation; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Male; Muscle, Skeletal; Obesity; Phosphorylation; Random Allocation; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors

2010
Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.
    Circulation research, 2010, Jun-25, Volume: 106, Issue:12

    Topics: Animals; Aorta; Apolipoproteins E; Calcinosis; Cattle; Cell Differentiation; Cells, Cultured; Chenodeoxycholic Acid; Chronic Disease; Disease Models, Animal; Kidney Diseases; Male; Mice; Mice, Knockout; Osteogenesis; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Triglycerides; Vascular Diseases

2010
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
    Gut, 2011, Volume: 60, Issue:4

    Topics: Animals; Caco-2 Cells; Chenodeoxycholic Acid; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation; Humans; Ileum; Inflammation Mediators; Inflammatory Bowel Diseases; Intestinal Absorption; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2011
Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus.
    Rheumatology international, 2012, Volume: 32, Issue:6

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Case-Control Studies; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Concanavalin A; Cytoprotection; Disease Models, Animal; Female; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-6; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha

2012
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA.
    Mini reviews in medicinal chemistry, 2011, Volume: 11, Issue:9

    Topics: Animals; Chenodeoxycholic Acid; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Liver Diseases; Metabolic Diseases; Receptors, Cytoplasmic and Nuclear

2011
Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit.
    The Journal of endocrinology, 2012, Volume: 212, Issue:1

    Topics: Androgens; Animals; Biomarkers; Chenodeoxycholic Acid; Dietary Fats; Disease Models, Animal; Drug Evaluation, Preclinical; Estradiol; Fibrosis; Male; Metabolic Syndrome; Prostate; Prostatitis; Rabbits; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Testosterone

2012
Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.
    American journal of physiology. Gastrointestinal and liver physiology, 2012, Jan-15, Volume: 302, Issue:2

    Topics: Animals; Animals, Newborn; Atrophy; Chenodeoxycholic Acid; Cholestasis; Disease Models, Animal; Fibroblast Growth Factors; Glucagon-Like Peptides; Intestinal Mucosa; Liver Diseases; Parenteral Nutrition, Total; Swine; Treatment Outcome

2012
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
    The Journal of steroid biochemistry and molecular biology, 2012, Volume: 132, Issue:1-2

    Topics: Androgens; Animals; Blood Glucose; Cell Movement; Chenodeoxycholic Acid; Cholesterol; Diet, High-Fat; Disease Models, Animal; Hypogonadism; Male; Metabolic Syndrome; Muscle Contraction; Myocytes, Smooth Muscle; Prostate; Rabbits; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Testosterone; Triglycerides; Triptorelin Pamoate; Urinary Bladder

2012
Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats.
    Kidney & blood pressure research, 2012, Volume: 36, Issue:1

    Topics: Animals; Biomarkers; Chenodeoxycholic Acid; Cytokines; Dietary Carbohydrates; Disease Models, Animal; Fibrosis; Fructose; Kidney; Lipid Metabolism; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nephritis; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Transforming Growth Factor beta1

2012
Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver.
    Biochimica et biophysica acta, 2002, Nov-20, Volume: 1588, Issue:2

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Bile; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestasis; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cricetinae; Cytochrome P-450 CYP3A; Disease Models, Animal; Down-Regulation; Liver; Microsomes, Liver; Models, Chemical; Oxidoreductases, N-Demethylating; RNA, Messenger; Steroid 12-alpha-Hydroxylase; Steroid Hydroxylases

2002
Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse.
    World journal of gastroenterology, 2007, Jun-14, Volume: 13, Issue:22

    Topics: Adenoviridae; Alkaline Phosphatase; Animals; Apoptosis; Cell Line; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Disease Models, Animal; Gene Expression Regulation; Humans; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Phenotype; Phosphoproteins; Transfection

2007
Tupaias (tree shrews) -- a new animal model for gallstone research. III. Cholesterol metabolism under different diets and CDCA.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1980, Volume: 178, Issue:1

    Topics: Animals; Bile; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Female; Intestinal Absorption; Liver; Tupaiidae

1980
[Promotion of adenocarcinomas at the preternatural anus by bile acids in rats (author's transl)].
    Langenbecks Archiv fur Chirurgie, 1980, Volume: 350, Issue:4

    Topics: Adenocarcinoma; Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cocarcinogenesis; Colon; Colonic Neoplasms; Colostomy; Disease Models, Animal; Intestinal Polyps; Neoplasms, Experimental; Rats; Time Factors

1980
Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis.
    Carcinogenesis, 1999, Volume: 20, Issue:2

    Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; beta Catenin; Carcinogenicity Tests; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cytoskeletal Proteins; Dinoprostone; Disease Models, Animal; Duodenal Neoplasms; Duodenum; Female; Mice; Trans-Activators

1999
Graded experimental acute pancreatitis: monitoring of a renewed rabbit model focusing on the production of interleukin-8 (IL-8) and CD11b/CD18.
    European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:2

    Topics: Acute Disease; Amylases; Animals; Ascites; CD11 Antigens; CD18 Antigens; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Models, Animal; Hyperglycemia; Hypocalcemia; Interleukin-8; Laparotomy; Leukopenia; Ligation; Lipase; Necrosis; Neutrophils; Pancreas; Pancreatic Ducts; Pancreatitis; Rabbits; Respiratory Distress Syndrome; Sodium Chloride; Tumor Necrosis Factor-alpha; Up-Regulation

1999
Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Lupus, 2001, Volume: 10, Issue:8

    Topics: Albuminuria; Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cytokines; Disease Models, Animal; Female; Gastrointestinal Agents; Hemocyanins; Immunization; Immunoglobulin G; Kidney; Liver; Lupus Nephritis; Mice; Mice, Inbred NZB; Spleen; Survival Rate; Uremia; Urodynamics; Ursodeoxycholic Acid

2001
Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
    The Journal of pharmacy and pharmacology, 2001, Volume: 53, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chenodeoxycholic Acid; Colitis, Ulcerative; Disease Models, Animal; Guinea Pigs; Mesalamine; Ursodeoxycholic Acid

2001
Failure of cholestyramine to prevent bile salt injury to mouse gastric mucosa.
    Gastroenterology, 1975, Volume: 68, Issue:6

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestyramine Resin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastric Mucosa; Gastritis; Hydrochloric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Mice; Stomach Ulcer; Taurocholic Acid

1975
Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
    Gastroenterology, 1979, Volume: 77, Issue:4 Pt 1

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cricetinae; Deoxycholic Acid; Disease Models, Animal; Female; Hydroxymethylglutaryl CoA Reductases; Liver; Mesocricetus

1979
Influence of primary bile acid feeding on cholesterol metabolism and hepatic function in the rhesus monkey.
    Mayo Clinic proceedings, 1975, Volume: 50, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bile; Bile Acids and Salts; Biopsy; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Cholic Acids; Deoxycholic Acid; Diet; Disease Models, Animal; Lithocholic Acid; Liver; Liver Function Tests; Macaca mulatta

1975
Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
    Life sciences, 1990, Volume: 46, Issue:23

    Topics: Animals; Bile; Bile Acids and Salts; Biliary Fistula; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chromatography, Gas; Cricetinae; Deoxycholic Acid; Disease Models, Animal; Lithocholic Acid; Male; Mesocricetus; Proteins; Ursodeoxycholic Acid

1990
Treatment of experimentally induced cerebral atherothromboembolism in an animal model with streptokinase and taurochenodeoxycholate.
    Artery, 1988, Volume: 15, Issue:5

    Topics: Animals; Chenodeoxycholic Acid; Disease Models, Animal; Intracranial Embolism and Thrombosis; Male; Rabbits; Streptokinase; Taurochenodeoxycholic Acid; Thromboembolism

1988
Dissolution of cholesterol gallstones by bile acids in the prairie dog.
    Lipids, 1988, Volume: 23, Issue:3

    Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Disease Models, Animal; Hydroxymethylglutaryl CoA Reductases; Male; Sciuridae; Ursodeoxycholic Acid

1988
Role of infected bile in spasm of the sphincter of oddi.
    American journal of surgery, 1973, Volume: 126, Issue:3

    Topics: Ampulla of Vater; Animals; Bile; Bile Acids and Salts; Biliary Tract Diseases; Cats; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Thin Layer; Deoxycholic Acid; Disease Models, Animal; Enterobacteriaceae Infections; Gallbladder; Liver; Muscle, Smooth; Perfusion; Pressure; Sodium; Sodium Chloride; Spasm; Time Factors

1973
Early changes in bile composition and gallstone formation induced by a high cholesterol diet in prairie dogs.
    Gastroenterology, 1974, Volume: 66, Issue:5

    Topics: Animals; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Cholesterol, Dietary; Cholic Acids; Crystallization; Diet, Atherogenic; Disease Models, Animal; Liver; Male; Phospholipids; Rodentia; Time Factors; Triglycerides

1974